Taiwan respiratory virus surge increases emergency room pressure

Taiwan is experiencing a simultaneous rise in respiratory infections, including influenza and COVID-19, leading to increased pressure on emergency departments. Recent data from the Centers for Disease Control shows that influenza-like illness outpatient visits exceeded 100,000 in a single week, a 5.6% increase from the previous week. The dominant circulating virus is Influenza A, specifically H1N1, which accounted for 74.1% of cases.

Medical professionals are debating infection control measures in response to the surge. While some doctors have implemented mandatory N95 mask usage for staff in emergency rooms to mitigate risks, others argue that the focus should be on isolating highly infectious patients rather than universal N95 use for droplet-transmitted viruses.

To combat the seasonal surge, enhanced influenza vaccines are being introduced. These new vaccines are expected to increase protection rates from approximately 50% to between 60% and 70%. The rollout includes 170,000 doses, with availability starting in early October. Experts also recommend that elderly populations consider pneumococcal vaccines as a secondary layer of defense against bacterial infections following viral illness.